Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
901
-
902
-
903
-
904
-
905
sGC expression remained constant, but cGMP and P-VASP/VASP ratio was decreased in aging resistance arteries; and FeTMPyP treatment reversed aging-related downregulation of the P-VA...
Published 2014“…<p>(A, B, D) sGC α1, sGC β1, cGMP, VASP and P-VASP immunostaining in resistance arteries. …”
-
906
-
907
-
908
-
909
-
910
-
911
-
912
-
913
-
914
-
915
-
916
-
917
The number of Brn3a-expressing cells in retino-collicular co-cultures decreases between DIV4 and DIV12.
Published 2013“…(B, C) The density of cells immunoreactive for Brn3a undergoes a reduction of ∼68% between DIV4 and DIV7, and a further decrease of ∼22% between DIV 7 and DIV12. …”
-
918
-
919
Linear regression analysis of decrease in viral load (VL) and trough concentrations of nevirapine (NVP C<sub>trough</sub>).
Published 2013“…<p>The log transformation of decrease in viral load (dlogVL) was significantly correlated with trough nevirapine concentrations (NVP Ctrough, µg/ml) among (A) all patients (r = 0.327, <i>p</i><0.05); and (B) patients with partial response (VL 50–400 copies/ml) and virologic failure (VL>400 copies/ml) (r = 0.619, <i>p</i><0.01).…”
-
920
Activation of Wnt/β-catenin signaling decreases mRNA expressions of <i>Scx</i>, <i>Mkx</i> and <i>Tnmd</i> in rat TDCs.
Published 2017“…<p>Relative expressions of <i>Axin2</i>, <i>Scx</i>, <i>Mkx</i>, and <i>Tnmd</i> in TDCs treated with 50 ng/ml Wnt3a with or without 5 μM IWR (an inhibitor of β-catenin) <b>(A)</b>, 0 to 4 μM BIO (an activator of β-catenin) <b>(B)</b>, or 0 to 20 μM IWR <b>(C)</b> for 72 hrs. …”